Global Adult Vaccines Market is expected to reach US$ XX Mn by 2026 from US$ XX Mn in 2019, at a CAGR of 7.5% during the forecast period.Global Adult Vaccines Market Overview:
Vaccines are biological preparations that are administered in an individual’s body to establish immunity to a particular disease. Adult’s immunity deteriorates over time, putting them at risk of contracting new infectious diseases. The vaccine contains some part of the disease-causing agent, which is either weakened or killed to the point that it cannot cause harm to the human body.Global Adult Vaccines Market Dynamics:
The increasing prevalence of contagious diseases globally is the major factor driving the market growth. Growing occurrences of contagious diseases such as influenza, hepatitis, zoster etc… and initiatives undertaken by the government to spread awareness about the importance of vaccination are the primary factors that encourage the adult vaccines market growth. In addition, the government's increasing partnerships with pharma and biopharma companies to develop novel vaccines would benefit the adult vaccines industry's growth in the forecast years. Apart from the government, non-governmental organisations are also now educating and encouraging adults to get vaccinations. During the forecast period, the presence of several NGOs is expected to be a driving factor in rising demand for adult vaccines in the global adult vaccines market. The WHO and UNICEF have issued recommendations on implementing a national immunisation programme in order to ensure that everyone in the world is vaccinated. All of these recent trends are expected to boost the global adult vaccines market. In recent times, there is an upsurge in infectious diseases such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola virus, Zika virus and others, which has increased the demand for the administration of vaccine worldwide. However, certain factors like high healthcare expenditure, lack of skilled professionals and stringent government regulations may restrain the adult vaccine market from growing. Along with this, limited production of vaccine and various side-effects associated with the vaccine such as muscular aches and fever may impact negatively the market growth. The report has profiled eighteen key players in the market from different regions. However, the report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for a future hot spot in APAC region.Global Adult Vaccines Market Segment Analysis:
The global Adult Vaccines Market is segmented on the basis of vaccine type, application and end-users. Based on Vaccine Type, the inactivated vaccine segment is expected to dominate the global market during forecast years. The increasing awareness of people about the advantages of vaccination is expected to aid the segment growth. Other features of inactivated vaccines such as long shelf life and high stability also contribute to the segment growth. In comparison to other conventional vaccines, the DNA vaccine is expected to develop at the fastest rate over the forecast period, owing to its high specificity and lower risk of introduction into the genome. Based on Application, the influenza segment holds a dominant market share. The segment dominance is attributed to the rising prevalence of various infections caused by the influenza virus such as acute respiratory syndrome, sinus problems, pneumonia and others. In the United States alone, influenza causes 36,000 annual deaths, and the total number of hospitalizations associated with influenza is estimated to be 226,000. The live influenza vaccines tend to be equivalent to TIVs in terms of preventive efficacy (trivalent, inactivated influenza vaccines.)To know about the Research Methodology :- Request Free Sample Report
Global Adult Vaccines Market Regional Insights:
North America is expected to account for the dominant market share over the forecast period, followed by Europe. Due to the presence of advanced healthcare infrastructure, Europe and North America dominate the global adult vaccines market. In North America, U.S. holds the major market share. Owing to the high prevalence of infectious diseases, increasing investments from the government, ongoing R&D activities and advancements in the development of novel vaccines boost the adult vaccines market in these regions. The Asia Pacific is expected to witness the fastest growth during the forecast period. Owing to rising vaccination awareness and increased immunisation initiatives, Asia-Pacific offers lucrative opportunities for the global Adult Vaccines market. Other factors contributing to the market growth in the region are the increase in vaccine demand, rise in geriatric population, increased awareness and continued government support for vaccine development. The report also helps in understanding the Global Adult Vaccines Market dynamics, structure by analyzing the market segments and project the Global Adult Vaccines Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Adult Vaccines Market make the report investor’s guide.
Global Adult Vaccines Market, Key Developments:
The ongoing COVID-19 pandemic has raised the demand for vaccine production worldwide. Due to this, many pharma companies and governmental organizations are collaborating to develop novel vaccine candidate against the SARS-CoV-2. Novavax and Serum Institute of India signed a licencing agreement in August 2020 for the production and commercialization of their novel COVID-19 vaccine candidate NVX-CoV2373 in low and middle-income countries, including India. This would increase the company's sales. Also, in February 2017, the Serum Institute of India collaborated with Cipla for the production of Hepatitis B vaccine for adults.Global Adult Vaccines Market Scope: Inquire before buying
Global Adult Vaccines Market, by Region
• North America • Europe • South America • MEA • APACGlobal Adult Vaccines Market, Key Players
• GlaxoSmithKline Plc • Merck & Co. • Sanofi Pasteur • Pfizer, Inc. • CSL Limited • Johnson & Johnson • Serum Institute of India • Medimmune • AstraZeneca Plc. • Novartis • Protein Sciences • Emergent BioSolutions • Bavarian Nordic • Mitsubishi Tanabe Pharma Corporation • Daiichi Sankyo Company • Dynavax Technologies Corporation • ImmunoBiology Ltd. • Novavax
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Adult Vaccines Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Adult Vaccines Market 3.4. Geographical Snapshot of the Adult Vaccines Market, By Manufacturer share 4. Global Adult Vaccines Market Overview, 2019-2026 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Adult Vaccines Market 5. Supply Side and Demand Side Indicators 6. Global Adult Vaccines Market Analysis and Forecast, 2019-2026 6.1. Global Adult Vaccines Market Size & Y-o-Y Growth Analysis. 7. Global Adult Vaccines Market Analysis and Forecasts, 2019-2026 7.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 7.1.1. Inactivated 7.1.2. Attenuated 7.1.3. Toxoid 7.1.4. Subunit 7.1.5. DNA Vaccines 7.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 7.2.1. Influenza 7.2.2. Tetanus/Diphtheria/Pertussis 7.2.3. Human Papillomavirus 7.2.4. Zoster 7.2.5. Pneumococcal 7.2.6. Hepatitis 7.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 7.3.1. Healthcare Firms 7.3.2. Hospital 8. Global Adult Vaccines Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2019-2026 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Adult Vaccines Market Analysis and Forecasts, 2019-2026 9.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 9.1.1. Inactivated 9.1.2. Attenuated 9.1.3. Toxoid 9.1.4. Subunit 9.1.5. DNA Vaccines 9.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 9.2.1. Influenza 9.2.2. Tetanus/Diphtheria/Pertussis 9.2.3. Human Papillomavirus 9.2.4. Zoster 9.2.5. Pneumococcal 9.2.6. Hepatitis 9.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 9.3.1. Healthcare Firms 9.3.2. Hospital 10. North America Adult Vaccines Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Adult Vaccines Market Analysis and Forecasts, 2019-2026 11.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 11.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 11.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 12. Canada Adult Vaccines Market Analysis and Forecasts, 2019-2026 12.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 12.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 12.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 13. Mexico Adult Vaccines Market Analysis and Forecasts, 2019-2026 13.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 13.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 13.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 14. Europe Adult Vaccines Market Analysis and Forecasts, 2019-2026 14.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 14.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 14.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 15. Europe Adult Vaccines Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Adult Vaccines Market Analysis and Forecasts, 2019-2026 16.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 16.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 16.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 17. France Adult Vaccines Market Analysis and Forecasts, 2019-2026 17.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 17.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 17.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 18. Germany Adult Vaccines Market Analysis and Forecasts, 2019-2026 18.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 18.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 18.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 19. Italy Adult Vaccines Market Analysis and Forecasts, 2019-2026 19.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 19.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 19.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 20. Spain Adult Vaccines Market Analysis and Forecasts, 2019-2026 20.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 20.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 20.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 21. Sweden Adult Vaccines Market Analysis and Forecasts, 2019-2026 21.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 21.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 21.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 22. CIS Countries Adult Vaccines Market Analysis and Forecasts, 2019-2026 22.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 22.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 22.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 23. Rest of Europe Adult Vaccines Market Analysis and Forecasts, 2019-2026 23.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 23.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 23.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 24. Asia Pacific Adult Vaccines Market Analysis and Forecasts, 2019-2026 24.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 24.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 24.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 25. Asia Pacific Adult Vaccines Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2019-2026 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Adult Vaccines Market Analysis and Forecasts, 2019-2026 26.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 26.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 26.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 27. India Adult Vaccines Market Analysis and Forecasts, 2019-2026 27.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 27.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 27.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 28. Japan Adult Vaccines Market Analysis and Forecasts, 2019-2026 28.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 28.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 28.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 29. South Korea Adult Vaccines Market Analysis and Forecasts, 2019-2026 29.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 29.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 29.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 30. Australia Adult Vaccines Market Analysis and Forecasts, 2019-2026 30.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 30.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 30.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 31. ASEAN Adult Vaccines Market Analysis and Forecasts, 2019-2026 31.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 31.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 31.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 32. Rest of Asia Pacific Adult Vaccines Market Analysis and Forecasts, 2019-2026 32.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 32.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 32.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 33. Middle East Africa Adult Vaccines Market Analysis and Forecasts, 2019-2026 33.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 33.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 33.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 34. Middle East Africa Adult Vaccines Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Adult Vaccines Market Analysis and Forecasts, 2019-2026 35.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 35.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 35.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 36. GCC Countries Adult Vaccines Market Analysis and Forecasts, 2019-2026 36.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 36.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 36.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 37. Egypt Adult Vaccines Market Analysis and Forecasts, 2019-2026 37.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 37.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 37.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 38. Nigeria Adult Vaccines Market Analysis and Forecasts, 2019-2026 38.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 38.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 38.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 39. Rest of ME&A Adult Vaccines Market Analysis and Forecasts, 2019-2026 39.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 39.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 39.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 40. South America Adult Vaccines Market Analysis and Forecasts, 2019-2026 40.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 40.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 40.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 41. South America Adult Vaccines Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2019-2026 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Adult Vaccines Market Analysis and Forecasts, 2019-2026 42.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 42.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 42.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 43. Argentina Adult Vaccines Market Analysis and Forecasts, 2019-2026 43.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 43.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 43.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 44. Rest of South America Adult Vaccines Market Analysis and Forecasts, 2019-2026 44.1. Market Size (Value) Estimates & Forecast By Vaccine Type, 2019-2026 44.2. Market Size (Value) Estimates & Forecast By Application, 2019-2026 44.3. Market Size (Value) Estimates & Forecast By End-Users, 2019-2026 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Adult Vaccines Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. GlaxoSmithKline Plc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. Merck & Co. 45.3.3. Sanofi Pasteur 45.3.4. Pfizer, Inc. 45.3.5. CSL Limited 45.3.6. Johnson & Johnson 45.3.7. Serum Institute of India 45.3.8. Medimmune 45.3.9. AstraZeneca Plc. 45.3.10. Novartis 45.3.11. Protein Sciences 45.3.12. Emergent BioSolutions 45.3.13. Bavarian Nordic 45.3.14. Mitsubishi Tanabe Pharma Corporation 45.3.15. Daiichi Sankyo Company 45.3.16. Dynavax Technologies Corporation 45.3.17. ImmunoBiology Ltd. 45.3.18. Novavax 46. Primary Key Insights